Medtronic Recalls Bravo CF Reflux Testing System After 184 Injuries
Medtronic initiated a global voluntary recall of certain Bravo calibration-free reflux testing system lots after reports of 184 serious injuries tied to a deployment control problem. The Bravo capsules may fail to attach or detach as intended, linked to a component controlling capsule deployment and possibly worsened if the delivery device is not kept straight. Customers were told to quarantine affected devices, and regulators were notified.